Craig M. Fisher
Dermatology | Military Health Care
1100 Wilford Hall Loop
Jbsa Lackland, TX 78236
Jbsa Lackland, TX 78236
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Atypical eccrine poroma of the buttock: Expanding the clinical spectrum of a rare benign neoplasm.
Journal: JAAD case reports
Published: February 16, 2026
Tirzepatide-induced lichen planus pigmentosus.
Journal: JAAD case reports
Published: December 15, 2025
JAAD Game Changers: Timing of potassium monitoring in females treated for acne with spironolactone is not optimal: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
JAAD Game Changer: Retrospective cohort study characterizing PD-1/PD-L1 checkpoint inhibition associated Stevens-Johnson syndrome and toxic epidermal necrolysis.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
JAAD Game Changers: Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
JAAD Game Changer: Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
JAAD Game Changer of the Year: Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
JAAD Game Changer: Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
JAAD Game Changer: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A randomized controlled trial in a real-world setting.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
JAAD Game Changers: Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
JAAD Game Changers: No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database.
Journal: Journal of the American Academy of Dermatology
Published: October 22, 2025
Last Updated: 09/26/2026